This image provided by Biogen on Monday, June 7, 2021 shows a vial and packaging for the drug Aduhelm. The first new Alzheimer’s treatment in more than 20 years was hailed as a breakthrough when regulators approved it in June 2021, but its rollout has been slowed by questions about its price and how well it works. Credit: Biogen via AP, File
The first new Alzheimer’s treatment in more than 20 years was hailed as a breakthrough when regulators approved it more than four months ago, but its rollout has been slowed by questions about its price and how well it works.
Several major medical centers remain undecided on whether to use Biogen’s Aduhelm, which is…
Слотмашины сегодня в множестве вариантов представлены в известных интернет-казино глобально. Вращать слоты в платном формате в онлайн-казино с компьютера , планшетов. Поскольку аппараты с...
